Mouse Anti-DBR1 Recombinant Antibody (3A7) (V2LY-0125-LY1164)

Xu, X., Yang, X., Liu, X., Bi, Y., Kong, P., Wang, Y., ... & Xi, Y. (2022). The Role of DBR1 as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment, 21, 15330338221083105.

Mohanta, A., & Chakrabarti, K. (2021). Dbr1 functions in mRNA processing, intron turnover and human diseases. Biochimie, 180, 134-142.

Valdés, J., Ortuño-Pineda, C., Saucedo-Cárdenas, O., & Mendoza-Figueroa, M. S. (2018). Unexplored Molecular Features of the Entamoeba histolytica RNA Lariat Debranching Enzyme Dbr1 Expression Profile. Frontiers in Cellular and Infection Microbiology, 8, 228.

Katolik, A., Clark, N. E., Tago, N., Montemayor, E. J., Hart, P. J., & Damha, M. J. (2017). Fluorescent Branched RNAs for High-Throughput Analysis of Dbr1 Enzyme Kinetics and Inhibition. ACS chemical biology, 12(3), 622-627.

Han, B., Park, H. K., Ching, T., Panneerselvam, J., Wang, H., Shen, Y., ... & Fei, P. (2017). Human DBR1 modulates the recycling of snRNPs to affect alternative RNA splicing and contributes to the suppression of cancer development. Oncogene, 36(38), 5382-5391.

Galvis, A. E., Fisher, H. E., Fan, H., & Camerini, D. (2017). Conformational changes in the 5′ end of the HIV-1 genome dependent on the debranching enzyme DBR1 during early stages of infection. Journal of Virology, 91(23), e01377-17.

Ransey, E., Paredes, E., Dey, S. K., Das, S. R., Heroux, A., & Macbeth, M. R. (2017). Crystal structure of the Entamoeba histolytica RNA lariat debranching enzyme EhDbr1 reveals a catalytic Zn2+/Mn2+ heterobinucleation. FEBS letters, 591(13), 2003-2010.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols